34 results
DEFA14A
EX-3.1
FWBI
First Wave BioPharma Inc
14 Mar 24
Additional proxy soliciting materials
6:10am
8-K
EX-3.1
FWBI
First Wave BioPharma Inc
14 Mar 24
Latiglutenase is a potentially first-in-class oral biotherapeutic for the treatment of celiac disease
6:09am
8-K
EX-3.1
FWBI
First Wave BioPharma Inc
14 Dec 23
First Wave BioPharma Announces 1-for-20 Reverse Stock Split and Results of the Special Meeting of Stockholders
9:15am
10-K
2022 FY
EX-3.1
FWBI
First Wave BioPharma Inc
Annual report
20 Mar 23
4:10pm
8-K
EX-3.1
FWBI
First Wave BioPharma Inc
17 Jan 23
First Wave BioPharma Announces Results of Special Meeting of Stockholders
9:15am
8-A12G
EX-3.1
h3hux eld1gl
28 Nov 22
Registration of securities
4:18pm
8-K
EX-3.1
scolnag4qm
25 Aug 22
First Wave BioPharma, Inc. Announces Reverse Stock Split
4:32pm
8-K
EX-3.1
w0j0 arhm8693s4o7
18 Jul 22
First Wave BioPharma, Inc. Announces Private Placement
5:00pm
8-K
EX-3.2
1pvcrxqvxv518pzcn
18 Jul 22
First Wave BioPharma, Inc. Announces Private Placement
5:00pm
8-K
EX-3.1
put55j0
7 Jul 22
Amendments to Articles of Incorporation or Bylaws
5:00pm
8-K
EX-3.1
yuokf vmsssw
17 Jun 22
Departure of Directors or Certain Officers
5:01pm
8-K
EX-3.2
o43085pcoyax044d1
17 Jun 22
Departure of Directors or Certain Officers
5:01pm
8-K
EX-3.1
wt0bz 6n6w13v6qtywm
14 Jan 22
Amendments to Articles of Incorporation or Bylaws
5:00pm